Home » Biotechnology » cDNA And oDNA Microchips Market

cDNA and oDNA Microchips Market By Application (Gene Identification & Detection, Comparative Genomic Hybridization, Gene Expression Profiling, Drug Discovery, Others); By End User (Research Organizations and Institutes, Biotech Companies, Clinical Laboratories) – Growth, Share, Opportunities & Competitive Analysis, 2024 – 2032

Name: cDNA And oDNA Microchips Market - Demand, Size and Competitive Analysis
Creator: Credence Research Inc.
Published: 2025-11-01
License: https://www.credenceresearch.com/info/privacy-policy
Keywords: cDNA And oDNA Microchips Market

Summary
Table Of Content
Request Free Sample

Market Overview

The Global cDNA and oDNA Microchips Market size was valued at USD 481.1 million in 2018, increased to USD 784.9 million in 2024, and is projected to reach USD 1,566.1 million by 2032, growing at a CAGR of 9.09% during the forecast period.

REPORT ATTRIBUTE	DETAILS
Historical Period	2020-2023
Base Year	2024
Forecast Period	2025-2032
cDNA and oDNA Microchips Market Size 2024	USD 784.9 million
cDNA and oDNA Microchips Market, CAGR	9.09%
cDNA and oDNA Microchips Market Size 2032	USD 1,566.1 million

The global cDNA and oDNA microchips market is highly competitive, with major players such as Life Technologies Corporation, Illumina Inc., Sequenom Inc., GE Healthcare, Thermo Fisher Scientific, Roche, and Guangzhou Daan Gene Co., Ltd. leading innovation and market expansion. These companies focus on technological advancements, strategic partnerships, and R&D investments to enhance product performance and application diversity. North America emerged as the leading region in 2024, commanding over 33% of the global market share, supported by advanced genomic research infrastructure, strong funding for biotechnology, and the early adoption of precision medicine and molecular diagnostic technologies.

cDNA And oDNA Microchips Market size

Market Insights

The Global cDNA and oDNA Microchips Market was valued at USD 784.9 million in 2024 and is projected to reach USD 1,566.1 million by 2032, growing at a CAGR of 9.09% during the forecast period.
Market growth is driven by increasing applications in genomic research, personalized medicine, and early disease diagnosis, supported by advancements in microarray technology and next-generation sequencing integration.
Emerging trends include the integration of AI and bioinformatics tools for data interpretation, accelerating gene analysis and improving clinical accuracy in genetic profiling.
The market is highly competitive, with Illumina Inc., Thermo Fisher Scientific, GE Healthcare, and Roche leading through R&D investments, product innovation, and global expansion strategies.
North America dominated with over 33% market share, followed by Europe at 27%, while gene expression profiling and research organizations remained the leading application and end-user segments in 2024.

Access crucial information at unmatched prices!

Request your sample report today & start making informed decisions powered by Credence Research Inc.!

Download Sample

Market Segmentation Analysis:

By Application

The global cDNA and oDNA microchips market by application is dominated by gene expression profiling, accounting for over 35% of the total market share in 2024. This segment leads due to its extensive use in studying gene activity, disease mechanisms, and personalized medicine. The demand is further driven by advancements in transcriptomics and the rising adoption of microarray technology in cancer research. Gene identification and detection follow closely, supported by increased clinical diagnostics usage. Meanwhile, comparative genomic hybridization and drug discovery segments continue to grow with expanding genomic applications in biotechnology and pharmacogenomics.

For instance, Illumina’s HumanHT-12 v4 Expression BeadChip enables the analysis of more than 47,000 transcripts, supporting large-scale cancer transcriptomics research.

By End User

Among end users, research organizations and institutes held the largest share, representing around 42% of the global market in 2024. Their dominance is attributed to the growing investment in genomics research, academic collaborations, and large-scale sequencing projects. Biotech companies form the second-largest segment, benefiting from increasing R&D in biomarker discovery and molecular diagnostics. Clinical laboratories are steadily expanding their adoption of cDNA and oDNA microchips for disease screening and precision medicine applications, supported by technological advancements and declining costs of microarray assays.

For instance, Amgen integrated single-cell transcriptomic profiling into its drug discovery pipeline to identify new therapeutic targets for autoimmune diseases.

Key Growth Drivers

Advancements in Genomic Research and Personalized Medicine

Rapid advancements in genomics and the increasing focus on personalized medicine are major drivers of the global cDNA and oDNA microchips market. The growing demand for genetic profiling to understand disease mechanisms and predict treatment responses has boosted microchip adoption across research and clinical settings. Integration of next-generation sequencing (NGS) data with microarray technology enhances gene expression analysis accuracy, driving innovation and application expansion in oncology, pharmacogenomics, and genetic disorder diagnostics.

For instance, the NHS Genomic Medicine Service in the UK is centralizing nationwide genomic efforts to customize cancer diagnostics and treatment plans, enhancing precision in oncology care.

Rising Investments in Biotechnology and Research Infrastructure

Expanding biotechnology research, supported by government funding and private sector investments, continues to strengthen market growth. Research institutes and universities are increasingly employing cDNA and oDNA microchips for functional genomics, molecular biology, and drug discovery applications. The proliferation of large-scale genome projects and public-private collaborations across North America, Europe, and Asia Pacific are enhancing access to advanced genetic tools, thereby accelerating adoption and creating significant opportunities for microchip manufacturers and service providers.

For instance, NantOmics integrates whole genome sequencing with proteomics to offer GPS Cancer, a comprehensive test that supports personalized cancer treatment strategies.

Growing Demand for Early Disease Diagnosis and Precision Healthcare

The increasing global emphasis on early disease detection and precision healthcare is driving the demand for cDNA and oDNA microchips. These microchips enable high-throughput genetic screening, allowing clinicians to detect gene mutations and expression changes linked to various diseases, including cancer and genetic disorders. The rising awareness of preventive diagnostics, coupled with technological improvements in microarray sensitivity and affordability, is propelling clinical adoption and supporting the market’s steady expansion across emerging and developed economies.

Key Trends & Opportunities

Integration of AI and Data Analytics in Genomic Interpretation

Artificial intelligence (AI) and advanced bioinformatics tools are reshaping data interpretation in genomic research. The integration of AI algorithms with cDNA and oDNA microchip platforms enhances data accuracy, speeds up gene expression analysis, and facilitates better disease correlation. This trend creates opportunities for developing intelligent diagnostic solutions and predictive genomics tools, enabling faster discovery of biomarkers and therapeutic targets, which is expected to redefine research and clinical diagnostics efficiency in the coming years.

For instance, Google’s DeepVariant utilizes convolutional neural networks to improve the precision of variant calling in whole-genome sequencing, reducing false positives significantly.

Emerging Applications in Drug Development and Pharmacogenomics

Expanding applications of cDNA and oDNA microchips in drug discovery and pharmacogenomics present substantial growth opportunities. Pharmaceutical companies increasingly use these technologies to identify genetic variations influencing drug response and to streamline target validation. The ability of microchips to support multi-gene analysis accelerates candidate screening, reduces development timelines, and enhances personalized drug formulation. This growing integration into the drug development pipeline positions the market for long-term expansion and innovation-led growth.

For instance, Roche developed the Amplichip CYP450, the first microarray approved for clinical use, which detects genetic variations in drug metabolism genes CYP2D6 and CYP2C19, facilitating personalized drug dosing.

cDNA And oDNA Microchips Market sharew

Key Challenges

High Cost of Microchip Technology and Data Management

Despite technological progress, the high cost associated with cDNA and oDNA microchips remains a significant challenge, particularly for small laboratories and research institutions. Expenses related to microarray fabrication, data analysis software, and skilled personnel limit accessibility in developing regions. Moreover, the large volume of genetic data generated requires advanced computational infrastructure and secure storage systems, adding further cost burdens that may restrain wider market adoption among resource-constrained organizations.

Complexity of Data Interpretation and Lack of Standardization

Interpreting large-scale genomic data from cDNA and oDNA microchips poses considerable complexity due to variability in assay performance and data processing methods. The absence of standardized protocols for gene expression analysis can lead to inconsistent results across studies. Additionally, limited interoperability between analytical platforms hinders data sharing and validation. These factors collectively slow clinical translation and reduce the reproducibility of research outcomes, posing ongoing challenges to market growth and application scalability.

Regional Analysis

North America

North America dominated the global cDNA and oDNA microchips market with a market share of over 33% in 2024, valued at USD 263.63 million, up from USD 164.12 million in 2018, and is projected to reach USD 515.09 million by 2032 at a CAGR of 8.8%. The region’s growth is driven by advanced genomic research infrastructure, strong funding for biotechnology, and the widespread adoption of personalized medicine. The U.S. leads the market due to the presence of major industry players, high R&D expenditure, and increasing integration of genomic technologies in clinical diagnostics.

Europe

Europe accounted for a significant 27% share of the global market in 2024, valued at USD 212.60 million, rising from USD 128.61 million in 2018 and expected to reach USD 431.62 million by 2032, expanding at a CAGR of 9.3%. The region benefits from strong regulatory support for genomic studies, high healthcare spending, and robust collaboration between research institutions and biotech firms. Countries like Germany, the UK, and France are leading innovation through government-backed genome programs and clinical application of DNA microchip technologies in disease diagnosis and therapeutics.

Asia Pacific

The Asia Pacific market represented about 24% of the global revenue in 2024, valued at USD 187.96 million, up from USD 114.94 million in 2018, and is projected to reach USD 376.18 million by 2032, growing at a CAGR of 9.1%. Growth in this region is driven by expanding biotechnology research, rising healthcare investments, and increased adoption of genomic tools across China, Japan, and India. Government initiatives promoting precision medicine and local manufacturing of genomic technologies are further accelerating market development and positioning Asia Pacific as a key growth hub in the coming years.

Latin America

Latin America accounted for approximately 10% of the global market in 2024, valued at USD 77.35 million, compared to USD 46.53 million in 2018, and is anticipated to reach USD 158.18 million by 2032, registering a CAGR of 9.4%. The region’s growth is supported by rising investments in biomedical research and growing awareness of genetic testing in countries such as Brazil and Argentina. Expanding healthcare infrastructure and regional collaborations with global biotech firms are improving access to advanced diagnostic tools, fostering steady adoption of cDNA and oDNA microchips across clinical and academic research institutions.

Middle East

The Middle East held a 6% share of the global market in 2024, reaching USD 35.18 million, up from USD 20.88 million in 2018, and is forecasted to attain USD 73.14 million by 2032, advancing at a CAGR of 9.6%. Growth in the region is fueled by increasing investments in genomic research, particularly in the GCC countries, Israel, and Turkey. National genomics initiatives and the expansion of precision healthcare programs are driving adoption. Strategic partnerships with international biotechnology firms are further enhancing the research ecosystem and supporting early disease detection through genomic technologies.

Africa

Africa represented a smaller share of around 2% of the global market in 2024, valued at USD 8.21 million, compared to USD 6.06 million in 2018, and is projected to reach USD 11.90 million by 2032, growing at a modest CAGR of 4.7%. Market growth is constrained by limited research funding, inadequate laboratory infrastructure, and slow adoption of genomic technologies. However, emerging initiatives in South Africa and Egypt focusing on genomic medicine and infectious disease research are expected to gradually enhance regional capacity and promote future growth opportunities in the cDNA and oDNA microchips market.

cDNA And oDNA Microchips Market segmentation

Market Segmentations:

By Application

Gene Identification & Detection
Comparative Genomic Hybridization
Gene Expression Profiling
Drug Discovery
Others

By End User

Research Organizations and Institutes
Biotech Companies
Clinical Laboratories

By Region

North America
- U.S.
- Canada
- Mexico
Europe
- Germany
- France
- U.K.
- Italy
- Spain
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- South Korea
- South-east Asia
- Rest of Asia Pacific
Latin America
- Brazil
- Argentina
- Rest of Latin America
Middle East & Africa
- GCC Countries
- South Africa
- Rest of the Middle East and Africa

Competitive Landscape

The competitive landscape of the global cDNA and oDNA microchips market is characterized by the presence of major players such as Life Technologies Corporation, Illumina Inc., Sequenom Inc., GE Healthcare, Thermo Fisher Scientific, Roche, and Guangzhou Daan Gene Co., Ltd. These companies focus on product innovation, strategic collaborations, and technological integration to strengthen their market positions. Continuous advancements in microarray technology, data analytics, and bioinformatics have intensified competition, driving firms to invest heavily in R&D to enhance accuracy, throughput, and application scope. Strategic mergers and acquisitions are common, enabling companies to expand their product portfolios and geographic reach. Furthermore, the growing emphasis on precision medicine and molecular diagnostics is encouraging partnerships between biotech firms and research institutions. Regional players are also gaining traction by offering cost-effective solutions tailored to emerging markets, making the competitive environment dynamic and innovation-driven across global and regional segments.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

Customize Now

Key Player Analysis

Life Technologies Corporation
Illumina, Inc.
Sequenom, Inc.
GE Healthcare
Thermo Fisher Scientific
Roche
Guangzhou Daan Gene Co., Ltd.
Other Key Players

Recent Developments

In October 2025, Illumina, Inc. introduced a new business unit named BioInsight, aimed at integrating omics data, advanced software, and AI tools to enhance life-science discovery and microarray-based research workflows.
In February 2025, Mitsui Chemicals, Inc. acquired a controlling stake in DNA Chip Research Inc. through a tender offer, making it a wholly owned subsidiary to strengthen its Life & Healthcare Solutions segment.
In October 2025, Illumina also launched its innovative 5-base solution, enabling simultaneous genomic and epigenomic analysis to advance multi-omic and microchip assay capabilities.

Report Coverage

The research report offers an in-depth analysis based on Application, End User and Region. It details leading market players, providing an overview of their business, product offerings, investments, revenue streams, and key applications. Additionally, the report includes insights into the competitive environment, SWOT analysis, current market trends, as well as the primary drivers and constraints. Furthermore, it discusses various factors that have driven market expansion in recent years. The report also explores market dynamics, regulatory scenarios, and technological advancements that are shaping the industry. It assesses the impact of external factors and global economic changes on market growth. Lastly, it provides strategic recommendations for new entrants and established companies to navigate the complexities of the market.

Future Outlook

The market is expected to witness steady growth driven by advancements in genomic research and personalized medicine.
Increasing adoption of cDNA and oDNA microchips in clinical diagnostics will strengthen healthcare applications.
Rising investments in biotechnology and research infrastructure will accelerate technology development.
Integration of AI and bioinformatics tools will enhance data analysis and improve result accuracy.
Expanding use of microchips in drug discovery and pharmacogenomics will support pharmaceutical innovation.
Emerging economies will experience higher adoption due to growing healthcare awareness and funding support.
Strategic collaborations between academic institutions and biotech firms will boost research efficiency.
Technological improvements will make microchip platforms more affordable and accessible.
Demand for precision and early disease detection will continue to drive clinical implementation.
Sustainable growth is anticipated as companies focus on innovation, automation, and data-driven genomic solutions.

CHAPTER NO. 1 : GENESIS OF THE MARKET

1.1 Market Prelude – Introduction & Scope

1.2 The Big Picture – Objectives & Vision

1.3 Strategic Edge – Unique Value Proposition

1.4 Stakeholder Compass – Key Beneficiaries

CHAPTER NO. 2 : EXECUTIVE LENS

2.1 Pulse of the Industry – Market Snapshot

2.2 Growth Arc – Revenue Projections (USD Million)

2.3. Premium Insights – Based on Primary Interviews

CHAPTER NO. 3 : CDNA AND ODNA MICROCHIPS MARKET FORCES & INDUSTRY PULSE

3.1 Foundations of Change – Market Overview
3.2 Catalysts of Expansion – Key Market Drivers
3.2.1 Momentum Boosters – Growth Triggers
3.2.2 Innovation Fuel – Disruptive Technologies
3.3 Headwinds & Crosswinds – Market Restraints
3.3.1 Regulatory Tides – Compliance Challenges
3.3.2 Economic Frictions – Inflationary Pressures
3.4 Untapped Horizons – Growth Potential & Opportunities
3.5 Strategic Navigation – Industry Frameworks
3.5.1 Market Equilibrium – Porter’s Five Forces
3.5.2 Ecosystem Dynamics – Value Chain Analysis
3.5.3 Macro Forces – PESTEL Breakdown

CHAPTER NO. 4 : KEY INVESTMENT EPICENTER

4.1 Regional Goldmines – High-Growth Geographies

4.2 Product Frontiers – Lucrative Application Categories

4.3 End User Sweet Spots – Emerging Demand Segments

CHAPTER NO. 5: REVENUE TRAJECTORY & WEALTH MAPPING

5.1 Momentum Metrics – Forecast & Growth Curves

5.2 Regional Revenue Footprint – Market Share Insights

5.3 Segmental Wealth Flow – Application & End User Revenue

CHAPTER NO. 6 : TRADE & COMMERCE ANALYSIS

6.1. Import Analysis By Region

6.1.1. Global CDNA And oDNA Microchips Market Import Revenue By Region

6.2. Export Analysis By Region

6.2.1. Global CDNA And oDNA Microchips Market Export Revenue By Region

CHAPTER NO. 7 : COMPETITION ANALYSIS

7.1. Company Market Share Analysis

7.1.1. Global CDNA And oDNA Microchips Market: Company Market Share

7.2. Global CDNA And oDNA Microchips Market Company Revenue Market Share

7.3. Strategic Developments

7.3.1. Acquisitions & Mergers

7.3.2. New Product Launch

7.3.3. Regional Expansion

7.4. Competitive Dashboard

7.5. Company Assessment Metrics, 2024

CHAPTER NO. 8 : CDNA AND ODNA MICROCHIPS MARKET – BY APPLICATION SEGMENT ANALYSIS

8.1. CDNA And oDNA Microchips Market Overview By Application Segment

8.1.1. CDNA And oDNA Microchips Market Revenue Share By Application

8.2. Gene Identification & Detection

8.3. Comparative Genomic Hybridization

8.4. Gene Expression Profiling

8.5. Drug Discovery

8.6. Other

CHAPTER NO. 9 : CDNA AND ODNA MICROCHIPS MARKET – BY END USER SEGMENT ANALYSIS

9.1. CDNA And oDNA Microchips Market Overview By End User Segment

9.1.1. CDNA And oDNA Microchips Market Revenue Share By End User

9.2. Research Organizations and Institutes

9.3. Biotech Companies

9.4. Clinical Laboratories

CHAPTER NO. 10 : CDNA AND ODNA MICROCHIPS MARKET – REGIONAL ANALYSIS

10.1. CDNA And oDNA Microchips Market Overview By Region Segment

10.1.1. Global CDNA And oDNA Microchips Market Revenue Share By Region

10.1.2. Regions

10.1.3. Global CDNA And oDNA Microchips Market Revenue By Region

10.1.4. Application

10.1.5. Global CDNA And oDNA Microchips Market Revenue By Application

10.1.6. End User

10.1.7. Global CDNA And oDNA Microchips Market Revenue By End User

CHAPTER NO. 11 : NORTH AMERICA CDNA AND ODNA MICROCHIPS MARKET – COUNTRY ANALYSIS

11.1. North America CDNA And oDNA Microchips Market Overview By Country Segment

11.1.1. North America CDNA And oDNA Microchips Market Revenue Share By Region

11.2. North America

11.2.1. North America CDNA And oDNA Microchips Market Revenue By Country

11.2.2. Application

11.2.3. North America CDNA And oDNA Microchips Market Revenue By Application

11.2.4. End User

11.2.5. North America CDNA And oDNA Microchips Market Revenue By End User

11.3. U.S.

11.4. Canada

11.5. Mexico

CHAPTER NO. 12 : EUROPE CDNA AND ODNA MICROCHIPS MARKET – COUNTRY ANALYSIS

12.1. Europe CDNA And oDNA Microchips Market Overview By Country Segment

12.1.1. Europe CDNA And oDNA Microchips Market Revenue Share By Region

12.2. Europe

12.2.1. Europe CDNA And oDNA Microchips Market Revenue By Country

12.2.2. Application

12.2.3. Europe CDNA And oDNA Microchips Market Revenue By Application

12.2.4. End User

12.2.5. Europe CDNA And oDNA Microchips Market Revenue By End User

12.3. UK

12.4. France

12.5. Germany

12.6. Italy

12.7. Spain

12.8. Russia

12.9. Rest of Europe

CHAPTER NO. 13 : ASIA PACIFIC CDNA AND ODNA MICROCHIPS MARKET – COUNTRY ANALYSIS

13.1. Asia Pacific CDNA And oDNA Microchips Market Overview By Country Segment

13.1.1. Asia Pacific CDNA And oDNA Microchips Market Revenue Share By Region

13.2. Asia Pacific

13.2.1. Asia Pacific CDNA And oDNA Microchips Market Revenue By Country

13.2.2. Application

13.2.3. Asia Pacific CDNA And oDNA Microchips Market Revenue By Application

13.2.4. End User

13.2.5. Asia Pacific CDNA And oDNA Microchips Market Revenue By End User

13.3. China

13.4. Japan

13.5. South Korea

13.6. India

13.7. Australia

13.8. Southeast Asia

13.9. Rest of Asia Pacific

CHAPTER NO. 14 : LATIN AMERICA CDNA AND ODNA MICROCHIPS MARKET – COUNTRY ANALYSIS

14.1. Latin America CDNA And oDNA Microchips Market Overview By Country Segment

14.1.1. Latin America CDNA And oDNA Microchips Market Revenue Share By Region

14.2. Latin America

14.2.1. Latin America CDNA And oDNA Microchips Market Revenue By Country

14.2.2. Application

14.2.3. Latin America CDNA And oDNA Microchips Market Revenue By Application

14.2.4. End User

14.2.5. Latin America CDNA And oDNA Microchips Market Revenue By End User

14.3. Brazil

14.4. Argentina

14.5. Rest of Latin America

CHAPTER NO. 15 : MIDDLE EAST CDNA AND ODNA MICROCHIPS MARKET – COUNTRY ANALYSIS

15.1. Middle East CDNA And oDNA Microchips Market Overview By Country Segment

15.1.1. Middle East CDNA And oDNA Microchips Market Revenue Share By Region

15.2. Middle East

15.2.1. Middle East CDNA And oDNA Microchips Market Revenue By Country

15.2.2. Application

15.2.3. Middle East CDNA And oDNA Microchips Market Revenue By Application

15.2.4. End User

15.2.5. Middle East CDNA And oDNA Microchips Market Revenue By End User

15.3. GCC Countries

15.4. Israel

15.5. Turkey

15.6. Rest of Middle East

CHAPTER NO. 16 : AFRICA CDNA AND ODNA MICROCHIPS MARKET – COUNTRY ANALYSIS

16.1. Africa CDNA And oDNA Microchips Market Overview By Country Segment

16.1.1. Africa CDNA And oDNA Microchips Market Revenue Share By Region

16.2. Africa

16.2.1. Africa CDNA And oDNA Microchips Market Revenue By Country

16.2.2. Application

16.2.3. Africa CDNA And oDNA Microchips Market Revenue By Application

16.2.4. End User

16.2.5. Africa CDNA And oDNA Microchips Market Revenue By End User

16.3. South Africa

16.4. Egypt

16.5. Rest of Africa

CHAPTER NO. 17 : COMPANY PROFILES

17.1. Life Technologies Corporation

17.1.2. Product Portfolio

17.1.3. Financial Overview

17.1.4. Recent Developments

17.1.5. Growth Strategy

17.1.6. SWOT Analysis

17.2. Illumina, Inc.

17.3. Sequenom, Inc.

17.4. GE Healthcare

17.5. Thermo Fisher Scientific

17.6. Roche

17.6. Guangzhou Daan Gene Co., Ltd

17.7. Other Key Players

Request A Free Sample

We prioritize the confidentiality and security of your data. Our promise: your information remains private.

Ready to Transform Data into Decisions?

Request Your Sample Report and Start Your Journey of Informed Choices

Providing the strategic compass for industry titans.

Frequently Asked Questions

What is the current market size for the Global cDNA and oDNA Microchips Market, and what is its projected size in 2032?

The Global cDNA and oDNA Microchips Market was valued at USD 784.9 million in 2024 and is projected to reach USD 1,566.1 million by 2032

At what Compound Annual Growth Rate is the Global cDNA and oDNA Microchips Market projected to grow between 2025 and 2032?

The Global cDNA and oDNA Microchips Market is expected to grow at a CAGR of 9.09% during the forecast period.

Which Global cDNA and oDNA Microchips Market segment held the largest share in 2024?

The gene expression profiling segment held the largest share of over 35% in the Global cDNA and oDNA Microchips Market in 2024.

What are the primary factors fueling the growth of the Global cDNA and oDNA Microchips Market?

Key growth drivers include advancements in genomic research, rising biotechnology investments, and increasing demand for precision medicine.

Who are the leading companies in the Global cDNA and oDNA Microchips Market?

Major players include Life Technologies Corporation, Illumina Inc., GE Healthcare, Thermo Fisher Scientific, and Roche.

Who are the major players in this Market?

Illumina, Inc.,Sequenom, Inc.,GE Healthcare,Thermo Fisher Scientific,Roche Nimblegen are some of the major players in the global market.

About Author

Shweta Bisht

Healthcare & Biotech Analyst

Shweta is a healthcare and biotech researcher with strong analytical skills in chemical and agri domains.

View Profile

Related Reports

Drug Discovery Technologies Market

Drug Discovery Technologies Market size was valued at USD 111.88 billion in 2024 and is anticipated to reach USD 273.07 billion by 2032, at a CAGR of 11.8% during the forecast period.

Retinol (Vitamin A) Market

Retinol (Vitamin A) Market size was valued USD 1009.6 million in 2024 and is anticipated to reach USD 1403.11 million by 2032, at a CAGR of 4.2% during the forecast period.

Liquid Biopsy Market

Liquid Biopsy market size reached USD 11.85 billion in 2024 and is projected to rise to USD 27.9 billion by 2032, supported by an 11.3% CAGR during the forecast period.

Biomarkers Market

Biomarkers Market size was valued at USD 56.41 Billion in 2024 and is anticipated to reach USD 126.29 Billion by 2032, at a CAGR of 10.6% during the forecast period.

Continuous Bioprocessing Market

Continuous Bioprocessing Market size was valued at USD 359.8 million in 2024 and is anticipated to reach USD 1220.45 million by 2032, at a CAGR of 16.5% during the forecast period.

In Vitro Colorectal Cancer Screening Market

The In vitro colorectal cancer screening market is projected to grow from USD 1,084.38 million in 2024 to USD 1,808.17 million by 2032, with a CAGR of 6.6% from 2024 to 2032.

Biological Microscope Objectives Market

Biological Microscope Objectives Market size was valued USD 2.04 billion in 2024 and is anticipated to reach USD 3.19 billion by 2032, at a CAGR of 5.75% during the forecast period.

Cell Isolation And Separation Market

The Cell Isolation and Separation Market size was valued at USD 5 billion in 2024 and is anticipated to reach USD 11.86 billion by 2032, at a CAGR of 12.6% during the forecast period.

Protein Engineering Market

Protein Engineering market was valued at USD 3 billion in 2024 and is anticipated to reach USD 9.71 billion by 2032, growing at a CAGR of 15.95 % during the forecast period.

Chromatography Reagents Market

Chromatography Reagents Market size was valued USD 6.81 billion in 2024 and is anticipated to reach USD 15.14 billion by 2032, at a CAGR of 10.5% during the forecast period.

Aptamers Market

Aptamers market was valued at USD 2.92 billion in 2024 and is anticipated to reach USD 16.76 billion by 2032, growing at a CAGR of 24.39% during the forecast period.

China and Europe Peptide Market

The China and Europe Peptide Market size was valued at USD 10,402.81 million in 2018, increased to USD 23,264.09 million in 2024, and is anticipated to reach USD 63,952.52 million by 2032, at a CAGR of 12.56% during the forecast period.

Licence Option

Single User

$4999

Multi User

$6999

Enterprise

$12999

Report delivery within 24 to 48 hours

Let us help you

WILLIAM, North America

+1 304 308 1216

KEITH PHILLIPS, Europe

+44 7809 866 263

LEE VALLANCE, Asia Pacific

+64 22 017 0275

KIERAN JAMESON, Australia

+61 4192 46279

Request A Free Sample

What people say?

Thank you for the data! The numbers are exactly what we asked for and what we need to build our business case.

Materials Scientist
(privacy requested)

The report was an excellent overview of the Industrial Burners market. This report does a great job of breaking everything down into manageable chunks.

Imre Hof
Management Assistant, Bekaert

Trusted By

Request Sample